
Sharon Kedar, CFA Questions Stagnation in Breast Cancer Surgery Innovation
In a recent LinkedIn post, Sharon Kedar, CFA questions the lack of innovation in breast cancer surgery over the past 30 years, advocating for a greater focus…

In a recent LinkedIn post, Sharon Kedar, CFA questions the lack of innovation in breast cancer surgery over the past 30 years, advocating for a greater focus…

In a recent LinkedIn post, Sharon Kedar, CFA discusses the critical need for innovation in early cancer detection, highlighting the transformative potential …

In a recent LinkedIn post, Sharon Kedar, CFA discusses the urgent need for innovation in breast cancer surgery, highlights gender-based reimbursement dispari…

In a recent LinkedIn post, Sharonkedar discusses the impact of the new 30-minute FDA-approved TriVerity blood test for sepsis, emphasizing the critical role …

In a recent LinkedIn post, Sharonkedar explores the vital role of supportive relationships in achieving ambitious goals. Drawing from personal experiences an…

In a recent LinkedIn post, Sharonkedar discusses the rapid nature of sepsis and highlights the recent FDA approval of Inflammatix, Inc.’s TriVerity blood tes…

In a recent LinkedIn post, Sharon Kedar, CFA discusses the significant healthspan disparity faced by women, highlighting that biological females are projecte…

In a recent LinkedIn post, Sharon Kedar, CFA discusses the critical need to correct the common misconception that women ‘finish’ menopause, highlighting adva…

In a recent LinkedIn post, Sharon Kedar, CFA discusses the newest episode of her podcast, “Human Health Innovators,” which features Amir Dan Rubin, former CE…

In a recent LinkedIn post, Sharon Kedar, CFA celebrates Allison Mignone, the Nasdaq 2026 Women’s Health Icon, highlighting Mignone’s establishment of the n…